Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Sands, E. Sapiejka, H. Mazurek, G. Gaszczyk (Warsaw, Gdansk, Rabka, Karpacz, Poland). Use of an electronic monitoring system to generate objective information on patients’ adherence to taking treatments of a novel inhaled tobramycin solution. Eur Respir J 2013; 42: Suppl. 57, 1188

Member's Comments

No comment yet.

Related content which might interest you: Use of a new feedback tool to optimize inhaled aerosol therapy in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 261s Year: 2006 Self-perceived verses electronic monitoring of adherence to nebulised treatment in children with cystic fibrosis - does the use of telehealth system improve nebulisation adherence? Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Nebulised antibiotics with the I-neb adaptive aerosol delivery (AAD) system: Impact on adherence in cystic fibrosis (CF) patients Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012 Optimal adherence with inhaled corticosteroids is related to better health status Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 The influence of type of inhalation device on adherence of COPD patients to inhaled medication Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Extent of inhaled drug deposition at variable inhaler inclination angles and airway geometries: An in-vivo study from a novel computational fluid dynamics model Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 The role of inhaled antibiotics in bronchial infection Source: Eur Respir Monogr 2013; 60: 120-126 Year: 2013 Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children Source: Eur Respir J, 50 (6) 1700910; 10.1183/13993003.00910-2017 Year: 2017 Precise dosing of five drugs commonly used by patients with cystic fibrosis using an adaptive aerosol delivery system Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Reducing the use of inhaled corticosteroids in mild COPD patients treated in primary care by a training program in national guidelines and using a portable device to measure pulmonary function Source: Eur Respir J 2005; 26: Suppl. 49, 294s Year: 2005 Safety profile of glycopyrronium in patients with COPD: An innovative approach to analyse data from post-marketing surveillance (PMS) Source: International Congress 2014 – Asthma and COPD management Year: 2014 A new tool for monitoring patient adherence with aerosol therapy using an eflow nebulizer system Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Home nebulizers: outcome of 151 inhaled therapy optimization assessments using methodology recommended in ERS nebulizer guidelines Source: Eur Respir J 2002; 20: Suppl. 38, 234s Year: 2002 Assessing symptoms in COPD: Use of the E-RS daily digital diary in early drug development Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Pulmonary targeted antibiotics in bronchiectasis; inhalers vs. nebulisers. A qualitative and quantitative assessment of patients’ attitudes Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Patients’ opinion for their inhalation device. An assessment of convenience and use Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation Source: Eur Respir J 2011; 38: 1328-1335 Year: 2011 Monitoring adherence to treatment regimen of inhaled medication use in a clinical trial with an investigational eFlow nebulizer (eTrack) Source: International Congress 2017 – Medical education, web and internet Year: 2017